BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 718420)

  • 1. Transformation and action of metrifonate.
    Nordgren I; Bergström M; Holmstedt B; Sandoz M
    Arch Toxicol; 1978 Oct; 41(1):31-41. PubMed ID: 718420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of metrifonate and dichlorvos during treatment of schistosomiasis with bilarcil.
    Nordgren I; Holmstedt B; Bengtsson E; Finkel Y
    Am J Trop Med Hyg; 1980 May; 29(3):426-30. PubMed ID: 7386721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of metrifonate and dichlorvos in blood and tissues by gas chromatography-mass spectrometry.
    Nordgren I
    Fundam Appl Toxicol; 1981; 1(2):230-7. PubMed ID: 7184787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metrifonate. Summary of toxicological and pharmacological information available.
    Holmstedt B; Nordgren I; Sandoz M; Sundwall A
    Arch Toxicol; 1978 Oct; 41(1):3-29. PubMed ID: 363095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.
    Nordgren I; Bengtsson E; Holmstedt B; Pettersson BM
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():79-86. PubMed ID: 7344416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
    Hinz V; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metrifonate and tacrine: a comparative study on their effect on acetylcholine dynamics in mouse brain.
    Nordgren I; Karlén B; Kimland M
    Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):236-40. PubMed ID: 1438050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
    Hinz VC; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):331-7. PubMed ID: 9139239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
    van der Staay FJ; Hinz VC; Schmidt BH
    J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esterases in schistosomes: reaction with substrates and inhibitors.
    Reiner E
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():72-8. PubMed ID: 7344415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.
    Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G
    Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes.
    Bueding E; Liu CL; Rogers SH
    Br J Pharmacol; 1972 Nov; 46(3):480-7. PubMed ID: 4656609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
    Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
    Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacology of metrifonate.
    Jann MW
    Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier.
    Rakonczay Z; Papp H
    Neurochem Int; 2001 Jul; 39(1):19-24. PubMed ID: 11311445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment.
    Dingemanse J; Halabi A; Kleinbloesem CH; Heinig R; Blume H
    Ther Drug Monit; 1999 Jun; 21(3):310-6. PubMed ID: 10365643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.
    Pettigrew LC; Bieber F; Lettieri J; Wermeling DP; Schmitt FA; Tikhtman AJ; Ashford JW; Smith CD; Wekstein DR; Markesbery WR; Orazem J; Ruzicka BB; Mas J; Gulanski B
    J Clin Pharmacol; 1998 Mar; 38(3):236-45. PubMed ID: 9549662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):1014-25. PubMed ID: 8784247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate (Trichlorphon).
    Reiner E; Krauthacker B; Simeon V; Skrinjarić-Spoljar M
    Biochem Pharmacol; 1975 Mar; 24(6):717-22. PubMed ID: 235931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.